In both optic nerve injury and glaucoma models, NRN1 has demonstrated the capacity to support the survival of RGCs and their neurite outgrowth, highlighting its therapeutic relevance (Sharma et al., 2015; Azuchi et al., 2018). The gene discussed is NRN1; the disease is glaucoma.